EUDA Health Holdings Limited (“EUDA” or the “Company”) (NASDAQ:
EUDA), a Singapore-based health technology company that operates a
first-of-its-kind Southeast Asian digital healthcare ecosystem,
proudly announces the successful completion of its acquisition of
CK Health Plus Sdn Bhd (“CK Health”) today. This strategic move
marks an expansion of EUDA's presence in Malaysia and underscores
its commitment to revolutionizing the healthcare landscape in the
region.
CK Health is a direct seller of holistic wellness consumer
products in Malaysia, committed to delivering high-quality products
that promote holistic well-being. With this acquisition, EUDA gains
access to CK Health's distribution network, customer base, and
expertise in the wellness industry.
EUDA's CEO Dr Kelvin Chen expressed excitement about the
acquisition, stating, "We are thrilled to welcome CK Health into
the EUDA family. This acquisition aligns seamlessly with our
mission to empower individuals to lead healthier lives through
innovative technology and holistic wellness solutions. Together, we
will leverage our combined strengths to drive positive health
outcomes and create lasting impact in the communities we
serve."
Management believes key benefits and synergies resulting from
the acquisition include:
1. Market Expansion: EUDA's acquisition of CK Health provides
entry into the Malaysian market, a key strategic move that enhances
the Company's regional presence and accelerates its growth
trajectory.
2. Diversification of Product Portfolio: By integrating CK
Health's range of holistic wellness products, EUDA enriches its
product offering, catering to a broader spectrum of health needs
and preferences.
3. Enhanced Distribution Channels: CK Health brings a network of
distributors and retailers, enabling EUDA to reach a wider audience
and drive market penetration effectively.
4. Complementary Expertise: The combination of EUDA's
technological prowess and CK Health's industry knowledge creates a
synergistic partnership poised for innovation and excellence in the
health and wellness sector.
EUDA remains committed to leveraging this strategic acquisition
to drive value for its stakeholders, including customers, partners,
and shareholders. With a shared vision for empowering individuals
to take control of their health and well-being, EUDA and CK Health
are poised to lead the charge towards a healthier, more vibrant
Southeast Asia.
For more information about EUDA Health Holdings Limited and its
innovative healthcare solutions, please visit www.euda.com.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited, is a Singapore-based health
technology company that operates a first-of-its-kind Southeast
Asian digital healthcare ecosystem aimed at making healthcare
affordable and accessible, and improving the patient experience by
delivering better outcomes through personalized healthcare. The
company’s proprietary unified AI platform quickly assesses a
patient’s medical history, triages a condition, digitally connects
patients with clinicians, and predicts optimal treatment outcomes.
EUDA’s holistic approach supports patients throughout all stages of
care, including wellness & prevention, urgent care &
emergencies, pre-existing conditions, and aftercare services.
Important Information for Investors and
Stockholders
This announcement relates to a proposed transaction by EUDA and
does not constitute an offer to sell or exchange, or the
solicitation of an offer to buy or exchange, any securities, nor
shall there be any sale of securities in any jurisdiction in which
such offer, sale or exchange would be unlawful prior to
registration or qualification under the securities laws of any such
jurisdiction.
Forward Looking Statements
Certain statements included in this press release are not
historical facts but are forward-looking statements.
Forward-looking statements generally are accompanied by words such
as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,”
“intend,” “expect,” “should,” “would,” “plan,” “future,” “outlook,”
and similar expressions that predict or indicate future events or
trends or that are not statements of historical matters, but the
absence of these words does not mean that a statement is not
forward-looking. These forward-looking statements include, but are
not limited to, statements regarding estimates and forecasts of
other performance metrics and projections of market opportunity.
These statements are based on various assumptions, whether or not
identified in this press release and on current expectations of
EUDA’s management and are not predictions of actual performance.
These forward-looking statements are provided for illustrative
purposes only and are not intended to serve as, and must not be
relied on by any investor as, a guarantee, an assurance, a
prediction or a definitive statement of fact or probability. Actual
events and circumstances are difficult or impossible to predict and
will differ from assumptions. Many actual events and circumstances
are beyond the control of EUDA. Some important factors that could
cause actual results to differ materially from those in any
forward-looking statements could include changes in domestic and
foreign business, market, financial, political and legal
conditions.
These forward-looking statements are subject to a number of
risks and uncertainties. These risks and uncertainties include, but
are not limited to, those factors described in the section entitled
“Risk Factors” in the Annual Report filed with the SEC on June 28,
2023. Important factors, among others, that may affect actual
results or outcomes include: the inability of the parties to
successfully or timely consummate the transaction, including the
risk that any required regulatory approvals are not obtained, are
delayed or are subject to unanticipated conditions that could
adversely affect EUDA or the expected benefits of the transaction,
if not obtained; the failure to realize the anticipated benefits of
the transaction; matters discovered by EUDA as it complete its due
diligence investigation of the other parties; costs related to the
transaction; the failure to satisfy the conditions to the
consummation of the transaction; the outcome of any legal
proceedings that may be instituted against EUDA related to the
transaction. Important factors that could cause EUDA’s actual
results or outcomes to differ materially from those discussed in
the forward-looking statements include: EUDA’s ability to manage
growth; EUDA’s ability to execute its business plan; EUDA’s
estimates of the size of the markets for its products and services;
the rate and degree of market acceptance of EUDA’s products and
services; EUDA’s ability to identify and integrate acquisitions;
potential litigation involving EUDA or the validity or
enforceability of intellectual property; and general economic and
market conditions impacting demand for EUDA’s products and
services.
If any of these risks materialize or our assumptions prove
incorrect, actual results could differ materially from the results
implied by these forward-looking statements. There may be
additional risks that EUDA presently know, or that EUDA currently
believe are immaterial that could also cause actual results to
differ from those contained in the forward-looking statements. In
addition, forward-looking statements reflect EUDA’s current
expectations, plans and forecasts of future events and views as of
the date hereof. Nothing in this press release should be regarded
as a representation by any person that the forward-looking
statements set forth herein will be achieved or that any of the
contemplated results of such forward-looking statements will be
achieved. You should not place undue reliance on forward-looking
statements in this press release, which speaks only as of the date
they are made and are qualified in their entirety by reference to
the cautionary statements herein and the risk factors described
above. EUDA anticipates that subsequent events and developments
will cause their assessments to change. However, while EUDA may
elect to update these forward-looking statements at some point in
the future, it specifically disclaims any obligation to do so,
except as required by law. These forward-looking statements should
not be relied upon as representing EUDA’s assessments as of any
date subsequent to the date of this press release. Accordingly,
undue reliance should not be placed upon the forward-looking
statements.
Contact:Christensen AdvisoryRoger
Hu852.2232.3968roger.hu@christensencomms.com
Euda Health (NASDAQ:EUDA)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Euda Health (NASDAQ:EUDA)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024